Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Chey

Showing results (181-190 of 300) with videos related to

Pageof 30
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|January 29, 2024
Percutaneous electrical nerve field stimulation for adolescents with irritable bowel syndrome: Cost-benefit and cost-minimization analysisEric Shah, Shanti Eswaran, Kimberly Harer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2017
A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable Bowel Syndrome and DiarrheaShanti Eswaran, William D Chey, Kenya Jackson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 18, 2022
Clinical History Does Not Reliably Predict Clinical Outcomes With Pelvic Floor Physical Therapy to Treat Chronic ConstipationEric D Shah, Michael A Curley, Tracy L Ostler, et al.
Digestive Diseases and Sciences|January 12, 2021
Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing AnalysisEric D Shah, Lin Chang, Anthony Lembo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel SyndromeShanti Eswaran, Kara J Jencks, Prashant Singh, et al.
The American Journal of Gastroenterology|September 17, 2009
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerabilityJay Luther, Peter D R Higgins, Phillip S Schoenfeld, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2002
Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathwaysEinar S Björnsson, William D Chey, Forrest Hooper, et al.
The American Journal of Gastroenterology|October 5, 2013
Mega-cecum: a novel clinical entity which explains overlapping gastrointestinal and urogynecologic symptoms in women with chronic constipationWilliam Y Chey, Vincent Chang, Maxine Lubukin, et al.
Therapeutic Advances in Gastroenterology|April 11, 2024
Long-term safety of tenapanor in people with irritable bowel syndrome with constipation from the T3MPO-3 study: plain language summary of publicationAnthony J Lembo, Susan Edelstein, David P Rosenbaum, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 18, 2024
Influence of patient characteristics on <i>Helicobacter pylori</i> eradication with Vonoprazan: A subgroup analysis of the pHalcon-HP trialWilliam D Chey, Francis Mégraud, Loren Laine, et al.
Pageof 30

Showing results (181-190 of 300) with videos related to

Sort By:
Pageof 30
Journal of Pediatric Gastroenterology and Nutrition|January 29, 2024
Percutaneous electrical nerve field stimulation for adolescents with irritable bowel syndrome: Cost-benefit and cost-minimization analysisEric Shah, Shanti Eswaran, Kimberly Harer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2017
A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable Bowel Syndrome and DiarrheaShanti Eswaran, William D Chey, Kenya Jackson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 18, 2022
Clinical History Does Not Reliably Predict Clinical Outcomes With Pelvic Floor Physical Therapy to Treat Chronic ConstipationEric D Shah, Michael A Curley, Tracy L Ostler, et al.
Digestive Diseases and Sciences|January 12, 2021
Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing AnalysisEric D Shah, Lin Chang, Anthony Lembo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
All FODMAPs Aren't Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel SyndromeShanti Eswaran, Kara J Jencks, Prashant Singh, et al.
The American Journal of Gastroenterology|September 17, 2009
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerabilityJay Luther, Peter D R Higgins, Phillip S Schoenfeld, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2002
Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathwaysEinar S Björnsson, William D Chey, Forrest Hooper, et al.
The American Journal of Gastroenterology|October 5, 2013
Mega-cecum: a novel clinical entity which explains overlapping gastrointestinal and urogynecologic symptoms in women with chronic constipationWilliam Y Chey, Vincent Chang, Maxine Lubukin, et al.
Therapeutic Advances in Gastroenterology|April 11, 2024
Long-term safety of tenapanor in people with irritable bowel syndrome with constipation from the T3MPO-3 study: plain language summary of publicationAnthony J Lembo, Susan Edelstein, David P Rosenbaum, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 18, 2024
Influence of patient characteristics on <i>Helicobacter pylori</i> eradication with Vonoprazan: A subgroup analysis of the pHalcon-HP trialWilliam D Chey, Francis Mégraud, Loren Laine, et al.
Pageof 30